Evidence map›Paper›PMID 38600455›Full record

ArticleMolecular medicine (Cambridge, Mass.)2024

Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues.

Franziska Hoschek, Julia Natan, Maximilian Wagner, Kirupa Sathasivam, Alshaimaa Abdelmoez, Björn von Einem, Gillian P Bates, G Bernhard Landwehrmeyer, Andreas Neueder

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Franziska HoschekDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Julia NatanDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Maximilian WagnerDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Kirupa SathasivamHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, WC1N 3BG, London, UK.
Alshaimaa AbdelmoezDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
Björn von EinemDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Gillian P BatesHuntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, WC1N 3BG, London, UK.
G Bernhard LandwehrmeyerDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Andreas NeuederDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany. andreas.neueder@uni-ulm.de.ORCID http://orcid.org/0000-0002-2389-5236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38600455
PMCPMC11005274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.